Pear Therapeuticsfiled for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the District of Delaware and intends to pursue a sale of the business or its assets.
“We also announced a reduction in force, including me,” Pear founder and now-former-CEO Corey McCann posted on social media on 7 April. “This is certainly not the outcome I...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?